Mounjaro (tirzepatide) is a dual GLP-1 and GIP receptor agonist licensed in the UK for type 2 diabetes mellitus. Whilst night sweats are not listed as an official adverse effect in the Summary of Product Characteristics, some patients have reported nocturnal perspiration whilst taking this medication. There is currently no established causal link between tirzepatide and night sweats based on clinical trial data. Night sweats can arise from numerous unrelated causes, including infections, hormonal imbalances, anxiety, and other health conditions. If you experience night sweats whilst taking Mounjaro, it is essential to discuss your symptoms with your GP or diabetes specialist nurse for appropriate assessment.

Does Mounjaro Cause Night Sweats?

Mounjaro (tirzepatide) is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus. In the UK, tirzepatide for weight management is available under a different brand name (Zepbound). Whilst night sweats are not listed as an adverse effect in the official Summary of Product Characteristics (SmPC) or patient information leaflet, some individuals taking Mounjaro have reported experiencing episodes of nocturnal perspiration.

It is important to recognise that there is no officially established causal link between tirzepatide and night sweats based on current clinical trial data and post-marketing surveillance. The pivotal SURPASS clinical trial programme, which evaluated tirzepatide's efficacy and safety, did not identify night sweats as a frequent or significant adverse event. However, individual patient experiences can vary, and it is theoretically possible that certain physiological changes associated with Mounjaro therapy might indirectly contribute to nocturnal sweating in some individuals.

Night sweats can arise from numerous causes unrelated to medication, including infections, hormonal imbalances (such as menopause or thyroid disorders), anxiety, and other underlying health conditions. Therefore, if you are experiencing night sweats whilst taking Mounjaro, it is essential to consider alternative explanations and discuss your symptoms with your GP or diabetes specialist nurse to ensure appropriate assessment and management.

Why Night Sweats May Occur with Mounjaro

Although night sweats are not a recognised side effect of Mounjaro, several theoretical mechanisms might potentially contribute to nocturnal perspiration in some patients. Tirzepatide works by mimicking the actions of incretin hormones, which enhance insulin secretion in response to meals, suppress glucagon release, slow gastric emptying, and promote satiety. These effects lead to improved glycaemic control and significant weight loss.

Hypoglycaemia (low blood glucose) is one potential contributor to night sweats, particularly when Mounjaro is used in combination with other glucose-lowering medications such as sulphonylureas or insulin. When initiating Mounjaro with these medications, your doctor may need to reduce their doses to minimise hypoglycaemia risk. Nocturnal hypoglycaemia can trigger a counter-regulatory response involving adrenaline release, which may manifest as sweating, palpitations, and tremor during sleep. However, tirzepatide monotherapy carries a low intrinsic risk of hypoglycaemia due to its glucose-dependent mechanism of action.

If you suspect nocturnal hypoglycaemia, your healthcare team may recommend checking your blood glucose levels upon waking or occasionally during the night if symptoms persist.

Rapid weight loss might theoretically affect body temperature regulation, though this connection remains speculative. Additionally, gastrointestinal side effects such as nausea or altered digestion might indirectly affect sleep quality and autonomic responses.

It is also worth noting that anxiety or heightened awareness of starting a new medication can sometimes manifest as physical symptoms, including increased perspiration. If night sweats persist or are accompanied by other concerning symptoms, further investigation is warranted to exclude unrelated medical conditions.

When to Seek Medical Advice About Night Sweats

Whilst occasional mild night sweats may not be cause for immediate concern, certain features warrant prompt medical evaluation. You should contact your GP or healthcare provider if:

• Night sweats are severe, persistent, or worsening over time

• You experience unintentional weight loss beyond what is expected from Mounjaro therapy

• Night sweats are accompanied by fever, chills, or signs of infection

• You notice fatigue, weakness, or unexplained changes in appetite

• There are symptoms suggestive of hypoglycaemia, such as confusion, tremor, palpitations, or waking feeling unwell

• You develop new or unusual symptoms such as lumps, persistent cough, or changes in bowel habits

• You experience severe, persistent abdominal pain radiating to the back (seek urgent medical attention as this could indicate pancreatitis)

These features may indicate underlying conditions that require investigation, such as infections (including tuberculosis), hyperthyroidism, lymphoma, or other systemic illnesses. Your GP will take a thorough history, perform a clinical examination, and may arrange blood tests or other investigations as appropriate.

If you suspect nocturnal hypoglycaemia, particularly if you are taking Mounjaro alongside insulin or sulphonylureas, discuss this with your diabetes care team promptly. They may recommend adjustments to your medication regimen or advise home blood glucose monitoring, including occasional checks during the night or upon waking.

Do not stop taking Mounjaro without medical advice, as abrupt discontinuation may affect your diabetes control. Always consult your prescriber before making changes to your treatment plan.

Managing Night Sweats While Taking Mounjaro

If you are experiencing night sweats whilst taking Mounjaro and serious underlying causes have been excluded, several practical strategies may help improve your comfort and sleep quality. Environmental modifications can make a significant difference: ensure your bedroom is well-ventilated and maintain a cool ambient temperature (around 18°C is considered optimal for sleep). Use breathable, moisture-wicking bedding and sleepwear made from natural fibres such as cotton or bamboo, and consider layering blankets so they can be easily adjusted during the night.

Lifestyle measures may also prove beneficial. Avoid known triggers of sweating before bedtime, including spicy foods, caffeine, and alcohol, all of which can affect thermoregulation and sleep architecture. Maintaining good hydration throughout the day is important, but try to limit fluid intake in the hour before sleep to reduce nighttime disturbances. Regular physical activity can improve overall metabolic health and sleep quality, though vigorous exercise should be completed at least three hours before bedtime.

If hypoglycaemia is suspected, work with your diabetes team to optimise your medication regimen and meal timing. Eating a small, balanced snack containing complex carbohydrates and protein before bed may help stabilise blood glucose levels overnight. Regular monitoring of blood glucose, particularly if symptoms are recurrent, can provide valuable information to guide treatment adjustments. If you use continuous glucose monitoring or flash glucose monitoring, this can be particularly helpful in identifying overnight patterns.

Stress management techniques such as mindfulness, relaxation exercises, or cognitive behavioural therapy for insomnia (CBT-I) may be helpful if anxiety or sleep disturbance is contributing to your symptoms. Keep a symptom diary noting the frequency and severity of night sweats, along with any potential triggers or associated symptoms, as this information will be valuable when discussing your concerns with healthcare professionals.

Other Common Side Effects of Mounjaro

Understanding the recognised adverse effect profile of Mounjaro can help patients distinguish between expected medication effects and symptoms that may require further investigation. Gastrointestinal side effects are the most frequently reported adverse reactions with tirzepatide therapy. These include nausea, diarrhoea, vomiting, constipation, abdominal pain, and dyspepsia (classified as very common in the SmPC). These symptoms are typically mild to moderate in severity, occur most commonly during dose escalation, and tend to diminish over time as the body adjusts to treatment. Eating smaller, low-fat meals and staying well-hydrated can help mitigate these effects.

Injection site reactions such as redness, itching, or mild discomfort may occur (classified as common) but are generally transient. Rotating injection sites (abdomen, thigh, or upper arm) and ensuring proper injection technique can minimise these reactions. Decreased appetite is also commonly reported, as part of the medication's intended mechanism for promoting weight loss.

As previously mentioned, hypoglycaemia risk is low with Mounjaro monotherapy but increases when combined with insulin or sulphonylureas. Patients should be educated about recognising and managing low blood glucose episodes. Other important adverse effects include acute pancreatitis (presenting as severe, persistent abdominal pain radiating to the back), gallbladder disease, and acute kidney injury, particularly in the context of severe gastrointestinal side effects leading to dehydration. If you experience severe abdominal pain, seek urgent medical attention; your doctor may advise temporarily stopping treatment if pancreatitis is suspected.

Diabetic retinopathy complications have been observed in clinical trials, particularly in patients with pre-existing retinopathy experiencing rapid glycaemic improvement. Regular eye screening as per NICE guidelines for diabetes care remains essential.

If you experience any suspected side effects while taking Mounjaro, you can report them via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or the Yellow Card app). If you experience any new, persistent, or concerning symptoms whilst taking Mounjaro, contact your healthcare provider promptly for assessment and guidance.

Frequently Asked Questions